FDA OKs Pembrolizumab for Adjuvant Treatment of NSCLC
The US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda) in the adjuvant setting for patients with stage IB-IIIA non–small ...
The US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda) in the adjuvant setting for patients with stage IB-IIIA non–small ...
Adult and adolescent patients with moderate to severe atopic dermatitis (AD) showed significant improvements with the addition of lebrikizumab to ...
Pros, Cons of Weight Loss Drugs The US recently approved new weight loss drugs that have become popular and carry ...
© 2022 Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical News Hubb All rights reserved.